Growth hormone pharmacogenetics: the interactive effect of a microsatellite in the IGF1 promoter region with the GHR-exon 3 and - 202 A/C IGFBP3 variants an treatment outcomes of children with severe GH deficiency (2011)
- Authors:
- USP affiliated authors: ANTONINI, SONIR ROBERTO RAUBER - FMRP ; MENDONÇA, BERENICE BILHARINHO DE - FM ; JORGE, ALEXANDER AUGUSTO DE LIMA - FM
- Unidades: FMRP; FM
- DOI: 10.1038/tpj.2011.13
- Subjects: FARMACOGENÉTICA; NANISMO; VARIAÇÃO GENÉTICA; HORMÔNIO DO CRESCIMENTO (DEFICIÊNCIA;TERAPIA;USO)
- Language: Inglês
- Imprenta:
- Source:
- Título: The Pharmacogenomics Journal
- ISSN: 1470-269X
- Volume/Número/Paginação/Ano: online, 2011
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
COSTALONGA, Everlayny Fiorot et al. Growth hormone pharmacogenetics: the interactive effect of a microsatellite in the IGF1 promoter region with the GHR-exon 3 and - 202 A/C IGFBP3 variants an treatment outcomes of children with severe GH deficiency. The Pharmacogenomics Journal, 2011Tradução . . Disponível em: https://doi.org/10.1038/tpj.2011.13. Acesso em: 03 jan. 2026. -
APA
Costalonga, E. F., Antonini, S. R. R., Guerra Júnior, G., Coletta, R. R. D., Franca, M. M., Braz, A. F., et al. (2011). Growth hormone pharmacogenetics: the interactive effect of a microsatellite in the IGF1 promoter region with the GHR-exon 3 and - 202 A/C IGFBP3 variants an treatment outcomes of children with severe GH deficiency. The Pharmacogenomics Journal. doi:10.1038/tpj.2011.13 -
NLM
Costalonga EF, Antonini SRR, Guerra Júnior G, Coletta RRD, Franca MM, Braz AF, Mendonça BB de, Arnhold IJP, Jorge AA de L. Growth hormone pharmacogenetics: the interactive effect of a microsatellite in the IGF1 promoter region with the GHR-exon 3 and - 202 A/C IGFBP3 variants an treatment outcomes of children with severe GH deficiency [Internet]. The Pharmacogenomics Journal. 2011 ;[citado 2026 jan. 03 ] Available from: https://doi.org/10.1038/tpj.2011.13 -
Vancouver
Costalonga EF, Antonini SRR, Guerra Júnior G, Coletta RRD, Franca MM, Braz AF, Mendonça BB de, Arnhold IJP, Jorge AA de L. Growth hormone pharmacogenetics: the interactive effect of a microsatellite in the IGF1 promoter region with the GHR-exon 3 and - 202 A/C IGFBP3 variants an treatment outcomes of children with severe GH deficiency [Internet]. The Pharmacogenomics Journal. 2011 ;[citado 2026 jan. 03 ] Available from: https://doi.org/10.1038/tpj.2011.13 - Genetic Predictors of Long-Term Response to Growth Hormone (GH) Therapy in Children With GH Deficiency and Turner Syndrome: the influence of a SOCS2 polymorphism
- Investigação genética
- Considerable frequency of novel GLI2 missense witations in patientes with hypopituitarism without holoprosencephaly
- A Bayesian approach to diagnose growth hormone deficiency in children: insulin-like growth factor type 1 is valuable for screening and IGF-binding protein type 3 for confirmation
- Exome sequencing reveals the POLR3H gene as a novel cause of primary ovarian insufficiency
- Rare causes and differential diagnosis in patients with Silver-Russell Syndrome
- GH-Releasing hormone receptor gene: a novel splice-disrupting mutation and study of founder effects
- IGF-1 assessed by pubertal status has the best positive predictive power for GH deficiency diagnosis in peripubertal children
- High-throughput splicing assays identify missense and silent splice-disruptive POU1F1 variants underlying pituitary hormone deficiency
- The sitting heigh/height ratio for age is a simple and useful tool to select children with idiopathic short stature for SHOX studies
Informações sobre o DOI: 10.1038/tpj.2011.13 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
